Murine bone marrow culture system for cytogenetic analysis

Area of Science:

• Toxicology
• Genetics
• Cell Biology

Background:

• Assessing the genotoxicity of chemical agents is crucial for risk assessment.
• Existing methods may have limitations in evaluating both in vivo and in vitro effects.
• A robust and reproducible assay is needed for comparative cytogenetic studies.

Purpose of the Study:

• To develop and validate a mouse bone marrow culture system for genotoxicity testing.
• To enable comparative in vivo and in vitro cytogenetic analysis.
• To optimize conditions for high mitotic yield and sister-chromatid exchange (SCE) analysis.

Main Methods:

• Establishing a primary mouse bone marrow cell culture from tibia and femora.
• Utilizing Ham's F-12 medium supplemented with fetal bovine serum and pregnant mouse uterus extract.
• Incorporating 5-bromo-2'-deoxyuridine (BrdU) for sister-chromatid exchange (SCE) analysis.
• Administering cyclophosphamide in vivo and trinitrofluorenone in vitro to assess genotoxic effects.

Main Results:

• The culture system demonstrated high mitotic yield, enhanced by flask culturing and uterus extract.
• Bromodeoxyuridine (BrdU) incorporation facilitated clear sister-chromatid exchange (SCE) analysis.
• Intraperitoneal injection of cyclophosphamide induced dose-related SCEs in cultured bone marrow cells.
• Direct-acting mutagen trinitrofluorenone caused dose-related SCEs in vitro.

Conclusions:

• The developed mouse bone marrow culture system is effective for in vitro genotoxicity assessment.
• The assay allows for comparative analysis of in vivo and in vitro genotoxic effects.
• This method provides a valuable tool for evaluating the cytogenetic damage induced by chemical agents.